Current Protein Identity:A0A3Q7RAT9 New Search
Main Difference Dimensions in This Set
Different construct Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
8XYZ The structure of fox ACE2 and PT RBD complex Deposited 2024-01-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–613(613 aa)
Not recorded ZN ZINC ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.96 Å
8XZB The structure of fox ACE2 and SARS-CoV RBD complex Deposited 2024-01-21 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–613(613 aa)
Not recorded ZN ZINC ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.12 Å
8XZD The structure of fox ACE2 and Omicron BF.7 RBD complex Deposited 2024-01-21 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1–613(613 aa)
Not recorded ZN ZINC ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 8
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.47 Å
9JTD Crystal structure of PCoV-GD receptor binding domain complexed with fox ACE2 Deposited 2024-10-04 Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 19–609(591 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291.15 K;0.2M Ammonium chloride, 20% w/v Polyethylene glycol 3350
Resolution 3.59 Å R-free 0.263
9JTD Crystal structure of PCoV-GD receptor binding domain complexed with fox ACE2 Deposited 2024-10-04 Assembly 3 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–609(591 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291.15 K;0.2M Ammonium chloride, 20% w/v Polyethylene glycol 3350
Resolution 3.59 Å R-free 0.263
9JTE Crystal structure of SARS-CoV-2 receptor binding domain complexed with fox ACE2 Deposited 2024-10-04 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 19–609(591 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291.15 K;0.2M Ammonium sulfate, 20% w/v Polyethylene glycol 3350
Resolution 3.66 Å R-free 0.249
9JTE Crystal structure of SARS-CoV-2 receptor binding domain complexed with fox ACE2 Deposited 2024-10-04 Assembly 2 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 19–609(591 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;291.15 K;0.2M Ammonium sulfate, 20% w/v Polyethylene glycol 3350
Resolution 3.66 Å R-free 0.249